POSA15 Evaluation of Efficacy and Safety of Nivolumab and Pembrolizumab in Elderly Cancer Patients
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.089
https://www.valueinhealthjournal.com/article/S1098-3015(21)01884-2/fulltext
Section Title :
Section Order :
10506
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01884-2&doi=10.1016/j.jval.2021.11.089